Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
82.1K
-
Shares change
-
-158K
-
Total reported value, excl. options
-
$2.43M
-
Value change
-
-$4.69M
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$29.58
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2023
4 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q4 2023.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.1K shares
of 66.6M outstanding shares and own 0.12% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.25M shares), VANGUARD GROUP INC (7.02M shares), Capital World Investors (6.38M shares), EMINENCE CAPITAL, LP (5.17M shares), FMR LLC (2.98M shares), ArrowMark Colorado Holdings LLC (2.94M shares), JANUS HENDERSON GROUP PLC (2.58M shares), STATE STREET CORP (2.27M shares), Bellevue Group AG (1.99M shares), and Champlain Investment Partners, LLC (1.53M shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.